Roquefort Therapeutics plc (ROQ.L)

GBp 3.85

(-10.47%)

Annual Cash Flows

(In GBP)
Breakdown 2023 2022 2021
Operating Cash Flow -1.73 Million -1.57 Million -2.62 Million
Net Income -1.74 Million -1.63 Million -917.43 Thousand
Depreciation & Amortization 3890.00 - -
Deferred income taxes - - -
Stock-based compensation 10.4 Thousand 8427.00 275.03 Thousand
Change in working capital -28.4 Thousand 39.43 Thousand -1.99 Million
Other non-cash items 73.12 Thousand 8968.00 2.27 Million
Investing Cash Flow -54.04 Thousand -103.47 Thousand -1.1 Million
Investments in PPE -54.04 Thousand - -
Acquisitions - -103.47 Thousand -1.1 Million
Investment purchases - - -
Sales/Maturities of investments - - -
Other Investing Activities 1469.00 - -
Financing Cash Flow -58.00 3.1 Million 4.62 Million
Debt repayment - - -
Dividends payments - - -
Common Stock Repurchased - - -
Common Stock Issuance - 3.12 Million 4.62 Million
Other Financing Activities -58.00 -18.99 Thousand 1.51 Million
Accounts receivables -55.85 Thousand -20.31 Thousand -2.13 Million
Accounts payables 27.44 Thousand 59.75 Thousand 129.52 Thousand
Inventory - - 9273.00
Other working capital 27.44 Thousand - -
Cash at beginning of period 2.32 Million 899.72 Thousand -153.00
Cash at end of period 537.32 Thousand 2.32 Million 899.72 Thousand
Capital Expenditure -54.04 Thousand - -
Effect of forex changes on cash 512.00 1995.00 -461.00
Net cash flow / Change in cash -1.78 Million 1.42 Million 899.87 Thousand
Free Cash Flow -1.78 Million -1.57 Million -2.62 Million

Cash Flow Charts